SCHEMBL30228226

SCHEMBL30228226

O=c1cc(-c2ccc(F)cc2Cl)c2ccc(O)cc2o1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 10/20 0.69
▸ CA9 Q16790 10/20 0.69
▸ HSD17B3 P37058 4/20 0.55
▸ AKR1B1 P15121 2/20 0.55
▸ MAOB P27338 2/20 0.55
▸ ALDH2 P05091 1/20 0.55
▸ MAOA P21397 1/20 0.55
▸ SORD Q00796 1/20 0.55
▸ KDM4E B2RXH2 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ HPGD P15428 2/20 0.51
▸ ESR1 P03372 3/20 0.49
▸ ESR2 Q92731 3/20 0.49
▸ NOD2 Q9HC29 1/20 0.49
▸ LMNA P02545 2/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ GLA P06280 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839408 1.00 CA12 (0.69) CA12CA9HSD17B3AKR1B1MAOB
SCHEMBL30598329 0.84 CA12 (0.63) CA12CA9HSD17B3AKR1B1MAOB
SCHEMBL20848059 0.84 CA12 (0.61) CA12CA9HSD17B3AKR1B1MAOB
SCHEMBL30228177 0.84 KDM4E (0.49) CA12CA9HSD17B3AKR1B1MAOB
SCHEMBL30228096 0.84 CA12 (0.48) CA12CA9MAOBKDM4EALDH1A1
SCHEMBL30227956 0.84 CA12 (0.48) CA12CA9HSD17B3AKR1B1MAOB
SCHEMBL26114135 0.84 CA12 (0.69) CA12CA9HSD17B3AKR1B1MAOB
SCHEMBL30228052 0.83 CA12 (0.48) CA12CA9HSD17B3AKR1B1MAOB
SCHEMBL30227959 0.83 CA9 (0.48) CA12CA9HSD17B3AKR1B1MAOB
SCHEMBL14424515 0.82 CA12 (0.75) CA12CA9HSD17B3AKR1B1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN disclosed
WO-2023034340-A1 HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-03-09 — — WO disclosed
WO-2023034346-A1 CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-03-09 — — WO disclosed
WO-2023034339-A1 HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-03-09 — — WO disclosed
Send feedback